In-vivo pilot efficacy test of a laser treatment device for skin rejuvenation

In-vivo pilot efficacy test of a laser treatment device for skin rejuvenation - Efficacy test for skin rejuvenation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON35046

Enrollment

Registered

2010-03-25

Start date

2010-05-18

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

huidveroudering fine lines wrinkles

Interventions

Liob creates microscopic isolated damage under the epidermis. This stimulates the natural healing proces and eventually the effect of skin rejuvenation.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy with wrinkle and/or fine lines (see inclusion criteria on page 29 in the protocol).

Exclusion criteria

Exclusion criteria: See extensive exclusion criteria on page 29-30 in the protocol

Design outcomes

Primary

Measure	Time frame
Improvement of appearance of wrinkles and/or fine lines.	—

Secondary

Measure	Time frame
Subjective assessment of skin wrinkle and/or fine line reduction. Sensation during the treatment.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)